- Home
- QUBT vs OGN Comparison
QUBT vs OGN Comparison
Compare QUBT & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QUBT
- OGN
- Stock Information
- Founded
- QUBT 2001
- OGN 1923
- Country
- QUBT United States
- OGN United States
- Employees
- QUBT N/A
- OGN N/A
- Industry
- QUBT Computer Manufacturing
- OGN Biotechnology: Pharmaceutical Preparations
- Sector
- QUBT Technology
- OGN Health Care
- Exchange
- QUBT Nasdaq
- OGN Nasdaq
- Market Cap
- QUBT 2.5B
- OGN 2.7B
- IPO Year
- QUBT N/A
- OGN N/A
- Fundamental
- Price
- QUBT $17.01
- OGN $10.67
- Analyst Decision
- QUBT Buy
- OGN Hold
- Analyst Count
- QUBT 2
- OGN 4
- Target Price
- QUBT $18.50
- OGN $18.00
- AVG Volume (30 Days)
- QUBT 15.8M
- OGN 3.6M
- Earning Date
- QUBT 11-05-2025
- OGN 10-30-2025
- Dividend Yield
- QUBT N/A
- OGN 0.75%
- EPS Growth
- QUBT N/A
- OGN N/A
- EPS
- QUBT N/A
- OGN 2.69
- Revenue
- QUBT $263,000.00
- OGN $6,281,000,000.00
- Revenue This Year
- QUBT $64.08
- OGN N/A
- Revenue Next Year
- QUBT $383.33
- OGN $1.36
- P/E Ratio
- QUBT N/A
- OGN $3.96
- Revenue Growth
- QUBT N/A
- OGN N/A
- 52 Week Low
- QUBT $0.64
- OGN $8.01
- 52 Week High
- QUBT $27.15
- OGN $21.06
- Technical
- Relative Strength Index (RSI)
- QUBT 58.27
- OGN 67.50
- Support Level
- QUBT $15.12
- OGN $10.13
- Resistance Level
- QUBT $16.28
- OGN $10.58
- Average True Range (ATR)
- QUBT 0.92
- OGN 0.36
- MACD
- QUBT 0.21
- OGN 0.15
- Stochastic Oscillator
- QUBT 91.82
- OGN 97.17
About QUBT Quantum Computing Inc.
Quantum Computing Inc is an integrated photonics and quantum optics technology company that provides accessible and affordable quantum machines to the world today. Its products are designed to operate at room temperature and low power at an affordable cost. The Company's portfolio of core technologies and products offer capabilities in the areas of high-performance computing, artificial intelligence, and cybersecurity, as well as remote sensing applications.
About OGN Organon & Co.
Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.